semaglutide shortage 2025 The weight loss drug is over — and some patients are 'panicking' FDA Ends Semaglutide Shortage Listing,
Description
Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category

In adipose tissue, GIPR promotes lipid storage and reduces lipolysis, contributing to energy balance

1.The success of Wegovy is just the beginning for GLP-1 medications

Patent law is only one part of a much broader equation.The growing burden of diabetes across Africa provides an opportunity to rethink how intellectual property, public health and industrial policy interact before the continent faces another access crisis.The legal tools already exist.The more difficult question is whether governments are prepared to use them and whether the international community is willing to support a model of pharmaceutical innovation that rewards research while recognising that access to essential medicines is, ultimately, a matter of public interest.This is a co-published article, originally published on WIPR.

But there's another tool that the research supports for muscle preservation and it involves sitting in a hot room
